Patent Case Watch

Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Valeant Pharmaceuticals v. Actavis Laboratories FL., Inc, No. 20-1201 (Fed. Cir. Dec. 18, 2020)

Affirmed
Rule 36 Affirmance
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 20-1201
Decided
December 18, 2020
Judge
Per curiam (Rule 36)
Document
Rule 36 Judgment
Length
2 pages
Download Opinion (PDF)

NOTE: This disposition is nonprecedential. United States Court of Appeals

for the Federal Circuit

VALEANT PHARMACEUTICALS

INTERNATIONAL, SALIX PHARMACEUTICALS

LTD., COSMO TECHNOLOGIES LIMITED,

Plaintiffs-Appellants

v.

ACTAVIS LABORATORIES FL., INC., ACTAVIS

PHARMA, INC., TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICAL INDUSTRIES

LTD.,

Defendants-Appellees

2020-1201

Appeal from the United States District Court for the District of Delaware in No. 1:18-cv-01288-LPS, Chief Judge Leonard P. Stark.

JUDGMENT

THOMAS P. STEINDLER, McDermott, Will & Emery LLP, Washington, DC, argued for all plaintiffs-appellants. Plaintiffs-appellants Valeant Pharmaceuticals International, Salix Pharmaceuticals Ltd. also represented by CHRISTOPHER MICHAEL BRUNO, PAUL MICHAEL

2SCHOENHARD.

GARY N. FRISCHLING, Milbank LLP, Los Angeles, CA, for plaintiff-appellant Cosmo Technologies Limited. Also represented by YITE JOHN LU. WILLIAM M. JAY, Goodwin Procter LLP, Washington, DC, argued for defendants-appellees. Also represented by JOHN T. BENNETT, GERARD JUSTIN CEDRONE, SAMUEL SHERRY, Boston, MA; ELIZABETH HOLLAND, New York, NY.

THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

PER CURIAM (NEWMAN, DYK, and REYNA, Circuit

Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

December 18, 2020 /s/ Peter R. Marksteiner

Date Peter R. Marksteiner

Clerk of Court

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Valeant Pharmaceuticals v. Actavis Laboratories FL., Inc, No. 20-1201 (Fed. Cir. Dec. 18, 2020).

Record ID
CAFC-20-1201-20201218
Permalink
https://patentcasewatch.com/opinions/CAFC-20-1201-20201218

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.

Source: Federal Circuit opinions and orders · retrieved August 15, 2026 · Report an error